Zota Health Care
Biotechnology · ZOTA
Small CapHealthcareHigh Growth
Moxesh Ketanbhai Zota
Managing Director · Pragmatic
Company DNA
Founder-Centric
About
Zota Health Care is a Small Cap company in the Healthcare sector, listed on NSE as ZOTA. With a market cap of ₹4K Cr and revenue of ₹293 Cr, it is currently in the High Growth phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Startup-Speed pace. Promoter-led healthcare entity with the founder actively involved in the Managing Director role, driving growth strategy. Its strategic mandate: Requires R&D-driven product expansion and niche portfolio scaling to break through in a crowded pharmaceutical market.
FAQ
What kind of company is Zota Health Care?
Zota Health Care is a Small Cap Healthcare company (ZOTA) in the High Growth phase with a market cap of ₹4K Cr. It is classified as Founder-Centric in culture.
What is Zota Health Care's culture and work environment like?
Zota Health Care has a Founder-Centric culture with Fast-Follower innovation DNA and a Startup-Speed pace of execution. Employee brand: Steady Employer. Customer relationship style: B2B-Enterprise. Promoter-led healthcare entity with the founder actively involved in the Managing Director role, driving growth strategy.
Who leads Zota Health Care?
Zota Health Care is led by Moxesh Ketanbhai Zota (Managing Director), a Pragmatic leader with 13 years of experience.
What are Zota Health Care's financials?
Zota Health Care reported revenue of ₹293 Cr in FY25 with a 5-year revenue CAGR of 30.7%. Operating margin: -16.4%. Market cap: ₹4K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceStartup-Speed
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployeeSteady Employer
BrandValue-Champion
LifecycleHigh Growth
Promoter-led healthcare entity with the founder actively involved in the Managing Director role, driving growth strategy.
Mandate
Requires R&D-driven product expansion and niche portfolio scaling to break through in a crowded pharmaceutical market.
Requires R&D-driven product expansion and niche portfolio scaling to break through in a crowded pharmaceutical market.
Financials
Revenue FY25₹293 Cr
PAT FY25₹-563984000
Rev CAGR 5Y30.7%
OPM-16.4%
NPM-19.3%
ROE-25.2%
ROCE-14.2%
P/E—
Fwd P/E—
P/B10.9
D/E56.9
Mkt Cap₹4K Cr
Promoter0%
Institutional0.1%
Similar Culture
Could You Lead Zota Health Care?
Take the Genome Benchmark →